Tenderwize
Back to tender search

Open-house rebate agreements for propranolol oral solution

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Nov 30, 2027 · 375 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Propranolol, als Lösung zum Einnehmen, ATC C07AA05

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

63 / 100

Risk factors

The notice provides no value, volume, minimum demand or guaranteed purchasing commitment.

The buyer may replace the open-house contracts with exclusive rebate contracts, causing automatic termination under the...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Nov 30, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Conclusion of non-exclusive pharmaceutical rebate agreements under sections 130a(8) and 130c(1) SGB V.
  • Scope limited to medicinal products containing propranolol as an oral solution, ATC C07AA05.
Show full summary

Open-house, non-exclusive pharmaceutical rebate agreements offered by AOK Rheinland-Pfalz/Saarland for propranolol oral solution (ATC C07AA05) in Germany. All interested pharmaceutical companies may join under uniform, non-negotiable conditions without a selection decision. The initial contract start was 1 February 2026, while later accessions are possible monthly until the stated 30 November 2027 deadline. The contract documents and commercial terms were not provided for analysis, and no contract value is stated.

Risks

The notice provides no value, volume, minimum demand or guaranteed purchasing commitment.

The buyer may replace the open-house contracts with exclusive rebate contracts, causing automatic termination under the...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Participation is limited to pharmaceutical companies.
  • Only medicinal products authorised and marketable in Germany may be supplied.
  • Products listed as marketable in the Lauer-Taxe satisfy the stated marketability proof requirement.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Propranolol Oral Solution Rebate Agreement

Non-exclusive open-house rebate agreement for medicinal products containing propranolol as an oral solution, ATC C07AA05. Only pharmaceutical companies and medicinal products authorised and marketable in Germany are eligible. Products covered by the BfArM children’s-medicines list under section 35(5a) SGB V are excluded. Contracts may be concluded monthly, have a maximum duration of 24 months from 1 February 2026, and may end automatically if exclusive rebate contracts replace them.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Nov 30, 2027

Procurement Details

Publication date
09 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
817662-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy